| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PDMP | CTRPv2 | pan-cancer | AAC | -0.094 | 0.01 |
| mRNA | etoposide | GDSC1000 | pan-cancer | AAC | -0.086 | 0.01 |
| mRNA | Gemcitabine | gCSI | pan-cancer | AAC | -0.14 | 0.01 |
| mRNA | Bosutinib | GDSC1000 | pan-cancer | AAC | -0.082 | 0.01 |
| mRNA | MLN2480 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.01 |
| mRNA | Nilotinib | CTRPv2 | pan-cancer | AAC | -0.091 | 0.01 |
| mRNA | SB-225002 | CTRPv2 | pan-cancer | AAC | -0.076 | 0.01 |
| mRNA | JW-480 | CTRPv2 | pan-cancer | AAC | -0.092 | 0.01 |
| mRNA | carboplatin:etoposide (40:17 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.072 | 0.02 |
| mRNA | lapatinib | CTRPv2 | pan-cancer | AAC | -0.087 | 0.02 |